CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is ...

GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Opens in a new tab or window Just over half of patients with overweight or obesity discontinued their GLP-1 receptor ... of diabetes status, every 1% of body weight loss was tied to a 3% lower ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease ... cancer and dementia, a sweeping new study shows.The research also points to important and perhaps ...